Product
KL003 cell injection
1 clinical trial
1 indication
Indication
Beta-ThalassemiaClinical trial
Evaluation of the Safety and Efficacy of KL003 Gene Therapy in Patients With Transfusion-dependent β-thalassemia With No Conditioning RegimenStatus: Recruiting, Estimated PCD: 2025-12-31